Pfizer-BioNTech COVID-19 Vaccine

As of  November 9th 2020, Pfizer and BioNTech industries have announced the production of a vaccine that has passed the final ‘phase III’ of human round testing. Based on evidence from clinical trials, the Pfizer-BioNTech vaccine was 95% effective at preventing laboratory-confirmed COVID-19 illness in people without evidence of previous infection.[…]

Read More »